These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33883925)

  • 1. Assessment of Weighted Gene Co-Expression Network Analysis to Explore Key Pathways and Novel Biomarkers in Muscular Dystrophy.
    Xu X; Hao Y; Wu J; Zhao J; Xiong S
    Pharmgenomics Pers Med; 2021; 14():431-444. PubMed ID: 33883925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the hub genes for Duchenne muscular dystrophy and Becker muscular dystrophy by weighted correlation network analysis.
    Wang J; Fan Q; Yu T; Zhang Y
    BMC Genom Data; 2021 Dec; 22(1):57. PubMed ID: 34922439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of hub genes related to Duchenne muscular dystrophy by weighted gene co-expression network analysis.
    Wei Y; Su Q; Li X
    Medicine (Baltimore); 2022 Dec; 101(52):e32603. PubMed ID: 36596079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Correlation Network Analysis to Identify Biomarkers of Peri-Implantitis.
    Sun B; Zhang W; Song X; Wu X
    Medicina (Kaunas); 2022 Aug; 58(8):. PubMed ID: 36013591
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of hub genes, miRNAs and regulatory factors relevant for Duchenne muscular dystrophy by bioinformatics analysis.
    Xiu MX; Zeng B; Kuang BH
    Int J Neurosci; 2022 Mar; 132(3):296-305. PubMed ID: 32791870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Long Non-coding RNA-Associated Competing Endogenous RNA Network in Duchenne Muscular Dystrophy.
    Xu X; Hao Y; Xiong S; He Z
    Interdiscip Sci; 2020 Dec; 12(4):447-460. PubMed ID: 32876881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weighted gene co-expression network analysis identifies specific modules and hub genes related to coronary artery disease.
    Zheng PF; Chen LZ; Guan YZ; Liu P
    Sci Rep; 2021 Mar; 11(1):6711. PubMed ID: 33758323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying hub genes and dysregulated pathways in Duchenne muscular dystrophy.
    Xin J; Liu S
    Int J Neurosci; 2024 Jan; ():1-13. PubMed ID: 38179963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weighted gene co-expression identification of CDKN1A as a hub inflammation gene following cardiopulmonary bypass in children with congenital heart disease.
    Chen H; Liu J; Wu Y; Jiang L; Tang M; Wang X; Fang X; Wang X
    Front Surg; 2022; 9():963850. PubMed ID: 36090322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-X-C motif chemokine ligand 12: a potential therapeutic target in Duchenne muscular dystrophy.
    Lai X; Chen J
    Bioengineered; 2021 Dec; 12(1):5428-5439. PubMed ID: 34424816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of biomarkers correlated with hypertrophic cardiomyopathy with co-expression analysis.
    Chen R; Ge T; Jiang W; Huo J; Chang Q; Geng J; Shan Q
    J Cell Physiol; 2019 Dec; 234(12):21999-22008. PubMed ID: 31059139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weighted gene co-expression network analysis to identify key modules and hub genes related to hyperlipidaemia.
    Liao FJ; Zheng PF; Guan YZ; Pan HW; Li W
    Nutr Metab (Lond); 2021 Mar; 18(1):24. PubMed ID: 33663541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Hub Genes in Duchenne Muscular Dystrophy: Evidence from Bioinformatic Analysis.
    Zhang R; Lv L; Ban W; Dang X; Zhang C
    J Comput Biol; 2020 Jan; 27(1):1-8. PubMed ID: 31390219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of vital modules and genes associated with heart failure based on weighted gene coexpression network analysis.
    Bian W; Wang Z; Li X; Jiang XX; Zhang H; Liu Z; Zhang DM
    ESC Heart Fail; 2022 Apr; 9(2):1370-1379. PubMed ID: 35128826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key biomarkers and latent pathways of dysferlinopathy: Bioinformatics analysis and
    Xie Y; Li YH; Chen K; Zhu CY; Bai JY; Xiao F; Tan S; Zeng L
    Front Neurol; 2022; 13():998251. PubMed ID: 36203997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Key Genes and Pathways in Myeloma side population cells by Bioinformatics Analysis.
    Yang Q; Li K; Li X; Liu J
    Int J Med Sci; 2020; 17(14):2063-2076. PubMed ID: 32922167
    [No Abstract]   [Full Text] [Related]  

  • 17. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring hub genes and crucial pathways linked to oxidative stress in bipolar disorder depressive episodes through bioinformatics analysis.
    Wu S; Hu H; Li Y; Ren Y
    Front Psychiatry; 2024; 15():1323527. PubMed ID: 38510807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profile analysis to predict potential biomarkers for glaucoma: BMP1, DMD and GEM.
    Zhang DW; Zhang S; Wu J
    PeerJ; 2020; 8():e9462. PubMed ID: 32953253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of
    Chen P; Yao M; Fang T; Ye C; Du Y; Jin Y; Wu R
    Pharmgenomics Pers Med; 2022; 15():377-392. PubMed ID: 35496348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.